Edward T. Mathers - Jun 9, 2021 Form 4/A - Amendment Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role: Director
Signature: /s/ Sasha Keough, attorney-in-fact
Stock symbol: RYTM
Transactions as of: Jun 9, 2021
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 6/16/2021, 04:16 PM
Date Of Original Report: Jun 11, 2021
Previous filing: Jun 8, 2021
Next filing: Jun 14, 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RYTM	Stock Option (right to buy)	Award	$0	+15K		$0.00	15K	Jun 9, 2021	Common Stock	15K	$18.99	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders.

Remarks:

On June 11, 2021, the Reporting Person filed a Form 4 which inadvertently reported the Date of Earliest Transaction (Item 3) as June 9, 2011 rather than June 9, 2021.